We congratulate Annals of Eye Science on obtaining its latest impact factor of 1.0 for the 2025 citation year! Over the past three years (from 2022 to 2025), Annals of Eye Science has demonstrated remarkable growth, with its SJR indicator increasing by 314%. During this period, the journal rose from the fourth quartile to a stable second quartile. This impressive trajectory places it among the fastestdeveloping ophthalmology journals. Indexation in Scopus and PubMed Central ensures strong visibility and citation potential. If the current trend continues, the journal has every chance of entering the first quartile within the next one to two years. For authors who prioritize open access and growthoriented publications, Annals of Eye Science represents an attractive platform, particularly in the fields of retinal and surgical ophthalmology, where we have seen excellent review articles devoted to the most compelling topics. For a growing number of authors, publishing in Annals of Eye Science opens up opportunities to advance together with the journal. With its remarkable growth, expanding visibility, and highquality content, Annals of Eye Science is well positioned to become one of the leading journals in ophthalmology, and we look forward to its continued success in the coming years.
Dmitrii S. Maltsev, MD, PhD, DSc
Editorial Board Member of AES
Head of medical retina division, Ophthalmology department, Military Medical Academy, St. Petersburg, Russia Clinical Professor, Ophthalmology department, Military Medical Academy, St. Petersburg, Russia
Written on August 10, 2026